C Bachert
GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients
Bousquet P, Gramiccioni C, Papadopoulos N, Haahtela T, Kowalski M, Magyar P, Muraközi G, Orosz M, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Bousquet J, Giavi S, Fokkens W, Burbach G, Heinzerling L, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica G, Darsow U, Durham S, Zuberbier T. GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy 2009; 64:1656-62.
01.11.2009GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients
01.11.2009Allergy 2009; 64:1656-62
Bousquet P-J, Gramiccioni C, Papadopoulos N G, Haahtela T, Kowalski M L, Magyar P, Muraközi G, Orosz M, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Bousquet J, Giavi S, Fokkens W J, Burbach G, Heinzerling Lucie, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica G W, Darsow U, Durham S, Zuberbier T
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe
Burbach G, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski M, Magyar P, Muraközi G, Orosz M, Papadopoulos N, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Giavi S, Fokkens W, Heinzerling L, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet P, Bresciani M, Bruno A, Canonica G, Darsow U, Demoly P, Durham S, Zuberbier T. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy 2009; 64:1507-15.
01.10.2009GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe
01.10.2009Allergy 2009; 64:1507-15
Burbach G J, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski M L, Magyar P, Muraközi G, Orosz M, Papadopoulos N G, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Giavi S, Fokkens W J, Heinzerling Lucie, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet P J, Bresciani M, Bruno A, Canonica G W, Darsow U, Demoly P, Durham S, Zuberbier T
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe
Heinzerling L, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski M, Magyar P, Muraközi G, Orosz M, Papadopoulos N, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Giavi S, Fokkens W, Durham S, Burbach G, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet P, Bresciani M, Bruno A, Burney P, Canonica G, Darsow U, Demoly P, Zuberbier T. GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy 2009; 64:1498-506.
01.10.2009GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe
01.10.2009Allergy 2009; 64:1498-506
Heinzerling Lucie, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski M L, Magyar P, Muraközi G, Orosz M, Papadopoulos N G, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Giavi S, Fokkens W J, Durham S, Burbach G J, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet P J, Bresciani M, Bruno A, Burney P, Canonica G W, Darsow U, Demoly P, Zuberbier T
[Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology]
Riechelmann H, German Society for Allergology and Clinical Immunology (ENT Section), Wagenmann M, Tasman A, Schlenter W, Klimek L, Hauswald B, Goldschmidt O, Bachert C, Working Team for Clinical Immunology. [Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology]. Laryngorhinootologie 2003; 82:183-8.
01.03.2003[Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology]
01.03.2003Laryngorhinootologie 2003; 82:183-8
Riechelmann H, German Society for Allergology and Clinical Immunology (ENT Section), Wagenmann M, Tasman Abel-Jan, Schlenter W W, Klimek L, Hauswald B, Goldschmidt O, Bachert C, Working Team for Clinical Immunology
Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group
Scadding G, Tasman A, Murrieta-Aguttes M, Bachert C. Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group. J Int Med Res 1999; 27:273-85.
01.01.1999Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group
01.01.1999J Int Med Res 1999; 27:273-85
Scadding G K, Tasman Abel-Jan, Murrieta-Aguttes M, Bachert C
Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group
Bachert C, Brostoff J, Scadding G, Tasman A, Stalla-Bourdillon A, Murrieta M. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group. Allergy 1998; 53:969-75.
01.10.1998Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group
01.10.1998Allergy 1998; 53:969-75
Bachert C, Brostoff J, Scadding G K, Tasman Abel-Jan, Stalla-Bourdillon A, Murrieta M